Fresh Tracks Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1990
Net Income	-5.69	-20.66	-39.52	-20.9	-25.95	-16.25	-12.96	-8.97	-9.24	-16.49	Upgrade
Depreciation & Amortization	0.04	0.03	0.02	0.01	0.03	0.05	0.79	1.12	1.16	1.66	Upgrade
Share-Based Compensation	1.92	2.16	2.26	1.99	1.53	0.71	0.76	0.99	1.9	3.16	Upgrade
Other Operating Activities	-0.61	-0.86	1.09	-1.13	-11.6	19.46	2.81	-1.52	-0.77	1.86	Upgrade
Operating Cash Flow	-4.34	-19.34	-36.15	-20.03	-35.98	3.97	-8.6	-8.39	-6.95	-9.81	Upgrade
Capital Expenditures	0	-0.05	-0.04	-0.02	-0.01	-0.01	-0.08	-0.26	-0.13	-0.35	Upgrade
Acquisitions	0	0	0	0	0	-1.29	0	0	0.05	0.27	Upgrade
Change in Investments	-	-	-	-4.5	-19.5	-89.7	-68.07	-68.79	-40.3	-33.2	Upgrade
Other Investing Activities	-	-	-	9	52.02	90.99	62.86	61.3	40.32	20.86	Upgrade
Investing Cash Flow	0	-0.05	-0.04	4.48	32.51	-0.01	-5.29	-7.74	-0.05	-12.43	Upgrade
Common Stock Issued	6.57	1.2	24.01	37.98	0	0	30.55	7.76	0	3.93	Upgrade
Share Repurchases	0	0.04	-0.05	0	0	0	0	0	0	0	Upgrade
Other Financing Activities	-0.04	0.02	8.9	0.46	2.64	-1.29	-0	-0.01	-0.02	-0.06	Upgrade
Financing Cash Flow	6.53	1.18	32.95	38.44	2.64	-1.29	30.55	7.74	-0.02	3.87	Upgrade
Net Cash Flow	2.19	-18.2	-3.23	22.88	-0.84	2.67	16.65	-8.38	-7.02	-18.37	Upgrade
Free Cash Flow	-4.34	-19.38	-36.18	-20.06	-35.99	3.96	-8.68	-8.64	-7.07	-10.16	Upgrade
Free Cash Flow Margin	-54.25%	-279.16%	-8956.44%	-1100.82%	-454.57%	243.83%	-62.82%	-59.48%	-33.76%	-66.77%	Upgrade
Free Cash Flow Per Share	-	-6.90	-20.27	-36.82	-535.71	57.04	-212.18	-271.74	-242.84	-360.46	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.